Canada markets closed

Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)

Shanghai - Shanghai Delayed Price. Currency in CNY
Add to watchlist
45.97-0.24 (-0.52%)
At close: 03:00PM CST
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
22,343,597
21,275,271
25,905,526
27,734,599
Cost of Revenue
3,475,445
3,486,639
3,741,799
3,348,690
Gross Profit
18,868,153
17,788,632
22,163,728
24,385,909
Operating Expenses
Research Development
5,114,509
4,886,553
5,943,306
4,988,958
Selling General and Administrative
9,553,139
9,098,676
11,438,881
12,029,867
Total Operating Expenses
15,087,804
14,443,911
18,080,090
17,907,511
Operating Income or Loss
3,780,349
3,344,721
4,083,638
6,478,398
Interest Expense
9,179
6,492
4,710
5,492
Income Before Tax
4,246,876
3,968,492
4,466,309
6,895,480
Income Tax Expense
76,822
153,421
-17,718
586,587
Income from Continuing Operations
4,170,054
3,815,071
4,484,027
6,308,893
Net Income
4,206,694
3,906,304
4,530,218
6,328,383
Net Income available to common shareholders
4,206,694
3,906,304
4,530,218
6,328,383
Basic EPS
0.66
0.61
0.71
0.99
Diluted EPS
0.66
0.61
0.71
0.99
Basic Average Shares
6,380,664
6,403,778
6,380,588
6,392,306
Diluted Average Shares
6,380,664
6,403,778
6,380,588
6,392,306